TITLE

ERCC5 expression a possible biomarker in ovarian cancer

AUTHOR(S)
Markman, Maurie; Harris, Jason; Shafer, Emily
PUB. DATE
July 2008
SOURCE
Hem/Onc Today;7/25/2008, Vol. 9 Issue 13, p28
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses research being done on the expression of the ERCC5 gene. It references a study published in the 2008 issue of the "Journal of Clinical Oncology." Study researchers conducted a whole-genome analysis in patients with ovarian cancer, who received cytoreductive surgery and adjuvant chemotherapy with platinum-based regimen. They found that ERCC5 gene expression can be a possible biomarker in ovarian cancer.
ACCESSION #
33230011

 

Related Articles

  • A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer. Hua Zhao; Jie Shen; Medico, Leonard; Dan Wang; Ambrosone, Christine B.; Song Liu // PLoS ONE;2010, Vol. 5 Issue 10, p1 

    Background: To date, there are no highly sensitive and specific minimally invasive biomarkers for detection of breast cancer at an early stage. The occurrence of circulating microRNAs (miRNAs) in blood components (including serum and plasma) has been repeatedly observed in cancer patients as...

  • Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer. Ferrandina, Gabriella; Mey, Valentina; Nannizzi, Sara; Ricciardi, Simona; Petrillo, Marco; Ferlini, Cristiano; Danesi, Romano; Scambia, Giovanni; Del Tacca, Mario // Cancer Chemotherapy & Pharmacology;Mar2010, Vol. 65 Issue 4, p679 

    Gemcitabine (2′,2′-difluorodeoxycytidine) (GEM) is one of the most actively investigated drugs in ovarian cancer. Many molecular mechanisms have been proposed to be involved in GEM sensitivity/resistance including the equilibrative nucleoside transporter-1 (hENT1), the concentrative...

  • MicroRNAs in cancer diagnosis and therapy: from bench to bedside. Hoshino, Isamu; Matsubara, Hisahiro // Surgery Today;May2013, Vol. 43 Issue 5, p467 

    Epigenetic changes, such as DNA methylation and histone modifications, regulate gene expression. It is speculated that investigating the fundamental epigenetic mechanisms and their gene regulation will promote a better understanding of cancer development. The idea of epigenetic modification has...

  • DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening. Shivapurkar, N.; Gazdar, A. F. // Current Molecular Medicine;Mar2010, Vol. 10 Issue 2, p123 

    DNA methylation plays a critical role in the regulation of gene expression, differentiation and in the development of cancer and other diseases. Hypermethylation of CpG islands located in the promoter regions of tumor suppressor genes is now firmly established as the most frequent mechanism for...

  • ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform. Rhodes, Daniel R.; Yu, Jianjun; Shanker, K.; Deshpande, Nandan; Varambally, Radhika; Ghosh, Debashis; Barrette, Terrence; Pandey, Akhilesh; Chinnaiyan, Arul M. // Neoplasia;Jan/Feb2004, Vol. 6 Issue 1, p1 

    DNA microarray technology has led to an explosion of oncogenomic analyses, generating a wealth of data and uncovering the complex gene expression patterns of cancer. Unfortunately, due to the lack of a unifying bioinformatic resource, the majority of these data sit stagnant and disjointed...

  • Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma. Liu, Na; Cui, Rui-Xue; He, Qing-Mei; Huang, Bi-Jun; Sun, Ying; Xie, Dan; Zeng, Jing; Wang, Hui-Yun; Ma, Jun // Medical Oncology;Mar2013, Vol. 30 Issue 1, p1 

    Dicer11 plays an important role in generation of microRNA and is dysregulated in a variety of human cancers. The purpose of this study was to evaluate Dicer11 expression and its prognostic value in nasopharyngeal carcinoma (NPC). The protein expression of Dicer1 was examined by...

  • Nanopore-based detection of circulating microRNAs in lung cancer patients. Wang, Yong; Zheng, Dali; Tan, Qiulin; Wang, Michael X.; Gu, Li-Qun // Nature Nanotechnology;Oct2011, Vol. 6 Issue 10, p668 

    MicroRNAs are short RNA molecules that regulate gene expression, and have been investigated as potential biomarkers because their expression levels are correlated with various diseases. However, detecting microRNAs in the bloodstream remains difficult because current methods are not sufficiently...

  • Histone modifications as markers of cancer prognosis: a cellular view. Kurdistani, S. K. // British Journal of Cancer;7/2/2007, Vol. 97 Issue 1, p1 

    Alterations in modifications of histones have been linked to deregulated expression of many genes with important roles in cancer development and progression. The effects of these alterations have so far been interpreted from a promoter-specific viewpoint, focussing on gene–gene...

  • Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. Torres, Anna; Torres, Kamil; Pesci, Anna; Ceccaroni, Marcello; Paszkowski, Tomasz; Cassandrini, Paola; Zamboni, Giuseppe; Maciejewski, Ryszard // BMC Cancer;2012, Vol. 12 Issue 1, p369 

    Background: Alterations of mTOR gene expression have been implicated in the pathogenesis of endometrioid endometrial cancer however only few studies explored the cause of increased mTOR activation in this malignancy. miRNAs are small, noncoding RNAs, which were proven to regulated gene...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics